Price
$1.26-61.82%Social Signal Score
Analyst Ratings
15 analystsRevenue
$613.23M-74.61%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Edward A. Pesicka
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 6,500
- Beta
- 1.52
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 0.27
Financials
Revenue
$613.23M-74.6%Net Income
$-89.07M-398.6%EBITDA
$12.61M-82.0%Free Cash Flow
$-73.59M-178.4%EPS (diluted)
$-1.16-341.7%Shares Outstanding (diluted)
76.70M+25.7%Operating Expenses
$243.56MCash & Debt
$7.65MReturn of Capital
$0.00Revenue by Segment (annual)
$1.38BDividend per Share
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.76B | $-1.10B | $-14.31 |
| 2024 | $10.70B | $-362.69M | $-4.73 |
| 2023 | $10.33B | $-41.30M | $-0.54 |
| 2022 | $9.96B | $22.39M | $0.30 |
| 2021 | $9.79B | $221.59M | $3.05 |
| 2020 | $8.48B | $29.87M | $0.47 |
| 2019 | $9.21B | $-62.37M | $-0.37 |
| 2018 | $9.42B | $-437.01M | $-7.28 |
| 2017 | $9.32B | $72.79M | $1.20 |
| 2016 | $9.72B | $108.79M | $1.76 |
| 2015 | $9.77B | $103.41M | $1.65 |
| 2014 | $9.44B | $66.50M | $1.06 |
| 2013 | $9.07B | $110.88M | $1.76 |
| 2012 | $8.91B | $109.00M | $1.72 |
Valuation
ACHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-69.07%Social Signal Score
Mentions (7)
- Newszacks.com·4h ago·Neutral
New Strong Sell Stocks for October 6th VLVLY, ACH and CCJ have been added to the Zacks Rank #5 (Strong Sell) List on October 6th, 2026.
View source ↗ - Newsbusinesswire.com·19d ago·Neutral
…neth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of Growth RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company's next President and Chief Executive Officer. Gardner-Smith, who has served on the Company's Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire…
View source ↗ - Newsbusinesswire.com·50d ago·Neutral
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The program was intended to allow the Company to opportunistically issue
View source ↗ - Newsseekingalpha.com·56d ago·Positive
Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript
View source ↗ - Newsbusinesswire.com·57d ago·Neutral
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company's ability to preserve its net operating loss carryforwards (“NOLs”) and certain other tax attributes. A company generall
View source ↗ - Newsbusinesswire.com·57d ago·Positive
Accendra Health Reports Second Quarter 2026 Financial Results RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Throughout the second quarter, we moved farther along toward the complete separation from Owen
View source ↗ - Newsbusinesswire.com·57d ago·Positive
Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company's Board of Directors before the end of the year. The Board of Director
View source ↗
Earnings
Thu, Oct 29(in 3 weeks)
Consensus estimate $-0.05 per share
Typical surprise +3.8% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 10$-0.19 vs $-0.08miss
- Mon, May 11$-0.04 vs $-0.06beat
- Thu, Feb 19$0.21 vs $0.22miss
- Thu, Oct 30$0.25 vs $0.23beat
- Mon, Aug 11$0.26 vs $0.27miss
- Thu, May 8$0.23 vs $0.20beat
Estimates and results for ACH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ACH officers and directors.
- Bought
- $42.9m
- Sold
- $1.2m
12 trades
12 trades
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
- Coliseum Capital Management, Llcbought
76 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ACH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.